| 刘大海杜建时韩冬梅马鹰刘卓△.干扰素在重度淋巴水肿综合治疗中的临床评价[J].,2012,12(23):4458-4460 |
| 干扰素在重度淋巴水肿综合治疗中的临床评价 |
| Clinical Evaluation of Interferon in the Comprehensive Treatment of SevereLymphedema Clinical Valuation |
| |
| DOI： |
| 中文关键词: 淋巴水肿 综合治疗 干扰素 |
| 英文关键词: Lymphedema Comprehensive treatment Interferon |
| 基金项目: |
|
| 摘要点击次数: 885 |
| 全文下载次数: 1253 |
| 中文摘要: |
| 目的：探讨干扰素在重度淋巴水肿综合治疗中的临床疗效。方法：将58 例重度淋巴水肿患者分为两组：对照组及加用干扰
素治疗组。治疗时间为2 个月。结果：对照组及干扰素治疗组的缓解率为100%。对照组显效率及有效率为别为42.9 %及57.1 %，
干扰素治疗组显效率及有效率分别为63.3 %和36.7 %，统计学分析，两组之间有显著性差异(P<0.05)。结论：加用干扰素的综合治
疗可提高重度淋巴水肿的缓解率。 |
| 英文摘要: |
| Objective: To investigate the role of interferon in the combined treatment of severe lymphedema. Methods: Fifty-eight
patients with severe lymphedema patients were divided into two groups: control group and the addition of interferon treatment group.
Treatment for 2 months. Results: Control group and the interferon treatment group response rates were 100 %. The control group
significant efficient and effective rate were 42.9 % and 57.1 %, interferon treatment group were 63.3 % and 36.7 %. The statistical
analysis between the two groups was significant difference (P<0.05). Conclusion: The comprehensive treatment with interferon in severe
lymphedema treatment can improve the response rate. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
